Terms: = Colorectal cancer AND SRSF3, SRp20, SFRS3, 6428, ENSG00000112081, P84103
19 results:
1. Impact of hospital volume on failure to rescue for complications requiring reoperation after elective colorectal surgery: multicentre propensity score-matched cohort study.
Grönroos-Korhonen MT; Koskenvuo LE; Mentula PJ; Nykänen TP; Koskensalo SK; Leppäniemi AK; Sallinen VJ
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38597158
[TBL] [Abstract] [Full Text] [Related]
2. Causes of death in patients operated for colorectal cancer.
Sonal S; Boudreau C; Lee GC; Cauley CE; Kunitake H; Goldstone RN; Francone TD; Bordeianou LG; Ricciardi R; Berger DL
Surgery; 2024 May; 175(5):1285-1290. PubMed ID: 38378348
[TBL] [Abstract] [Full Text] [Related]
3. Homeobox B9 Promotes Colon cancer Progression by Targeting srsf3.
Yuan L; Cheng F; Wu Z; Li X; Shen W
Dig Dis Sci; 2023 Aug; 68(8):3324-3340. PubMed ID: 37258980
[TBL] [Abstract] [Full Text] [Related]
4. Genetic compensation response could exist in colorectal cancer: UPF3A upregulates the oncogenic homologue gene srsf3 expression corresponding to SRSF6 to promote colorectal cancer metastasis.
Xu W; Ou W; Feng Y; Xu Q; Yang Y; Cui L; Du P
J Gastroenterol Hepatol; 2023 Apr; 38(4):634-647. PubMed ID: 36807382
[TBL] [Abstract] [Full Text] [Related]
5. Panomics reveals patient individuality as the major driver of colorectal cancer progression.
Praus F; Künstner A; Sauer T; Kohl M; Kern K; Deichmann S; Végvári Á; Keck T; Busch H; Habermann JK; Gemoll T
J Transl Med; 2023 Jan; 21(1):41. PubMed ID: 36691026
[TBL] [Abstract] [Full Text] [Related]
6. LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating srsf3.
Luo J; Gao K; Chen M; Tian B
Pathol Res Pract; 2022 Jun; 234():153905. PubMed ID: 35462226
[TBL] [Abstract] [Full Text] [Related]
7. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.
Hui B; Lu C; Wang J; Xu Y; Yang Y; Ji H; Li X; Xu L; Wang J; Tang W; Wang K; Gu Y
J Cell Physiol; 2022 Jan; 237(1):911-933. PubMed ID: 34463962
[TBL] [Abstract] [Full Text] [Related]
8. The srsf3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract] [Full Text] [Related]
9. B7-H3 is spliced by srsf3 in colorectal cancer.
Zhang C; Chen Y; Li F; Yang M; Meng F; Zhang Y; Chen W; Wang W
Cancer Immunol Immunother; 2021 Feb; 70(2):311-321. PubMed ID: 32719950
[TBL] [Abstract] [Full Text] [Related]
10. srsf3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of cancer-Specific Energy Metabolism in Colon cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract] [Full Text] [Related]
11. RBM4-srsf3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
[TBL] [Abstract] [Full Text] [Related]
12. Proteomic Characterization of Transcription and Splicing Factors Associated with a Metastatic Phenotype in colorectal cancer.
Torres S; García-Palmero I; Marín-Vicente C; Bartolomé RA; Calviño E; Fernández-Aceñero MJ; Casal JI
J Proteome Res; 2018 Jan; 17(1):252-264. PubMed ID: 29131639
[TBL] [Abstract] [Full Text] [Related]
13. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
Park WC; Kim HR; Kang DB; Ryu JS; Choi KH; Lee GO; Yun KJ; Kim KY; Park R; Yoon KH; Cho JH; Lee YJ; Chae SC; Park MC; Park DS
BMC Cancer; 2016 Jun; 16():358. PubMed ID: 27282379
[TBL] [Abstract] [Full Text] [Related]
14. Oxidative stress-inducible truncated serine/arginine-rich splicing factor 3 regulates interleukin-8 production in human colon cancer cells.
Kano S; Nishida K; Kurebe H; Nishiyama C; Kita K; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2014 Feb; 306(3):C250-62. PubMed ID: 24284797
[TBL] [Abstract] [Full Text] [Related]
15. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells.
Kurokawa K; Akaike Y; Masuda K; Kuwano Y; Nishida K; Yamagishi N; Kajita K; Tanahashi T; Rokutan K
Oncogene; 2014 Mar; 33(11):1407-17. PubMed ID: 23503458
[TBL] [Abstract] [Full Text] [Related]
16. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of srp20 that is potentially involved in tumorigenicity.
Corbo C; Orrù S; Gemei M; Noto RD; Mirabelli P; Imperlini E; Ruoppolo M; Vecchio LD; Salvatore F
Proteomics; 2012 Jun; 12(12):2045-59. PubMed ID: 22623141
[TBL] [Abstract] [Full Text] [Related]
17. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract] [Full Text] [Related]
18. The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of srp20 expression.
Gonçalves V; Matos P; Jordan P
RNA; 2008 Dec; 14(12):2538-49. PubMed ID: 18952824
[TBL] [Abstract] [Full Text] [Related]
19. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.
Ghigna C; Moroni M; Porta C; Riva S; Biamonti G
Cancer Res; 1998 Dec; 58(24):5818-24. PubMed ID: 9865741
[TBL] [Abstract] [Full Text] [Related]
